Welcome to our dedicated page for Global Medical SEC filings (Ticker: GMRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lease escalators, tenant credit metrics, and reimbursement risks often hide deep inside Global Medical REIT Inc. (GMRE) disclosures—details that can make or break a dividend thesis. If you have ever searched for “Global Medical REIT insider trading Form 4 transactions” or wondered where last quarter’s rent coverage ratios are buried, you know the challenge.
Stock Titan solves that problem. Our AI reads every 10-K, 10-Q, 8-K, and DEF 14A the moment it hits EDGAR, then delivers plain-language explanations. Think “Global Medical REIT annual report 10-K simplified” or “Global Medical REIT quarterly earnings report 10-Q filing decoded”. Key numbers—cash NOI, weighted-average lease term, dividend payout ratio—are surfaced so you can focus on decisions, not page counts.
Need real-time alerts? Form 4 insider data streams in seconds, giving you “Global Medical REIT Form 4 insider transactions real-time” visibility into executive stock moves. Our dashboard also links each “Global Medical REIT proxy statement executive compensation” to historical pay trends and flags any outsized awards. Material events? “Global Medical REIT 8-K material events explained” stories summarize new acquisitions or lease amendments in a paragraph.
- Track acquisition cap rates across filings with AI-powered summaries
- Compare quarter-over-quarter rental revenue without wading through tables
- Monitor “Global Medical REIT earnings report filing analysis” minutes after release
Whether you’re a yield-focused investor or an analyst modeling tenant coverage, understanding Global Medical REIT SEC documents with AI lets you act faster and with greater confidence.
Global Medical REIT (NYSE:GMRE) Form 4 discloses that newly appointed CEO and President Mark Okey Decker Jr. purchased 160,000 common shares on 24-25 June 2025 at a weighted average price of about $6.52, committing roughly $1.0 million of personal capital. Following the transactions, he directly owns 160,000 shares.
On 23 June 2025 he also received 158,730 Long-Term Incentive Plan (LTIP) units, exchangeable one-for-one for common stock after vesting on the third anniversary of grant.
- Transaction code: P (open-market purchases)
- Ownership form: Direct
- No Rule 10b5-1 plan indicated
The >$1 million insider buy by the CEO is a potentially positive signal of management confidence and tighter alignment with shareholder interests.
Form 3 filing overview: Global Medical REIT Inc. (GMRE) submitted an Initial Statement of Beneficial Ownership (Form 3) on 25 June 2025 for Mark Okey Decker Jr., who is listed as both Director and President & CEO.
Key details
- Date of event: 23 June 2025
- Securities owned: None – the filing explicitly states “No securities are beneficially owned.”
- Signatory: /s/ Jamie Barber acting under Power of Attorney dated 23 June 2025.
The document satisfies Section 16(a) initial reporting requirements and indicates the new executive currently holds zero GMRE common shares or derivative securities, leaving open the possibility of future insider acquisitions that would require subsequent Form 4 disclosures.
Global Medical REIT Inc. (NYSE: GMRE) filed an 8-K disclosing a CEO transition effective 23 Jun 2025. Jeffrey M. Busch has been removed as Chief Executive Officer and President and will remain non-executive Chairman. The Board simultaneously appointed Mark O. Decker, Jr. (age 49) as CEO, President and Board member, expanding the Board from seven to eight seats.
The filing provides a detailed three-year employment agreement between Inter-American Management LLC and Mr. Decker:
- Base salary: $700,000 per year.
- Target annual cash bonus: ≥100 % of base salary, prorated for 2025 (60 % cash / 40 % LTIP Units).
- Equity incentives: one-time $1 million LTIP award on the Effective Date; $1.2 million target LTIP award for 2026.
- Relocation stipend: $75,000.
Severance for a "Qualifying Termination" equals 2× (base salary + greater of target or prior-year bonus), pro-rated bonus, accelerated vesting of equity, and up to 18 months of subsidized health coverage. Enhanced benefits (up to 3× multiplier) apply upon qualifying terminations linked to a change in control. Definitions of "good reason" and "cause" are standard for REIT executives.
Mr. Decker’s prior roles include Managing Partner at Proterra Value Investors (2023-2025) and CEO/CIO of Centerspace (NYSE: CSR, 2017-2023). The filing states no family relationships or related-party transactions.
FAQ
What is the current stock price of Global Medical (GMRE)?
What is the market cap of Global Medical (GMRE)?
What is the core business of Global Medical REIT Inc?
How does Global Medical REIT generate its revenue?
What is the significance of triple-net leases in its business model?
Who are typically the tenants in Global Medical REIT's properties?
How does the company differentiate itself from its competitors?
In which markets does Global Medical REIT invest?
How does the company's portfolio structure mitigate risks?
What industry terminology is essential to understanding Global Medical REIT's operations?
